B2B Proposal for Hospitals and Clinics

Expand your services with

BHIAG as a Partner

We offer a comprehensive partnership model that enables hospitals and clinical centres to enter the field of longevity and regenerative medicine without any initial investment, generating new sources of revenue backed by world-class scientific expertise.

0+
Expert Teachers
0+
Years of experience
0+
Training Hours
0+
Countries Represented

passive income

Turnkey Training

Comprehensive support for hospitals that wish to offer quality training and masters without fixed costs or development management.

  • +1500 hours of e-learning training
  • 180+ chapters and 54+ specialized modules
  • Developed by 40 teachers from 15 countries
  • Degrees in Regenerative Medicine and Biohacking
  • Leading positioning in advanced training
  • Source of recurring passive income

active income

Longevity Unit

Creation and implementation of regenerative medicine and biohacking units to attract high value private clients worldwide successfully sustainably.

  • State-of-the-art protocols
  • cutting-edge treatments
  • Capture of private premium customers
  • Synergy with institutions of credibility
  • differential positioning in the sector
  • Comprehensive implementation support

Why partner with BHIAG?

We take advantage of the synergy and credibility of large institutions to position themselves
as leaders in an exponential growing sector.

No initial investment

Turnkey model with no fixed costs of development or operational management or additional initial investment

academic credibility

Support of +600 years of combined clinical experience and 40 international experts across multiple disciplines.

Validated protocols

State-of-the-art treatments and protocols already tested in Dubai, Europe and America with proven results

Strategic Partnership

Alliance with a leading globally recognized institution in longevity, biohacking and advanced comprehensive health.

Ready to transform your institution?

Join the global network of medical centers leading the future of regenerative medicine and longevity.